Clinical Study On Treatment Of Mild Cognitive Impairment By Bushenjianpi

Objective:To investigate the clinical efficacy of yiyuanfuzhi self-treatment to mild cognitive impairment,and from the traditional medicine point of view research its etiology of disease.Methods:According to the internationlly recognized diagnostic criterion of mild cognitive impairment, selected 62 cases of patients with MCI, randomized grouping, divided into treatment group (n=30) and control group (n=32).30 cases in treated group take Yiyuanfuzhi self-treatment ; 32 cases in control group take Brovincamine. Patients will be observed before and after the scale mini-mental state examination(MMSE),The Montreal Cognitive Assessment ( MoCA ) , the symptoms of traditional chinese medicine(TCM) after 3months course of treatment。Results:In the treatment groupand thecontrol group before and after treatment in MMSE scores,MoCA scores,the scores of symptoms of TCM on the difference between statistical significance(p<0.05);Comparsion of the two group before and after treatment in MMSE scores,MoCA scores,the difference Was not statistically significant by statistical tests(P>0.05 ),but in Chinese medicine syndromes integration on the margin of compariso,there are statistically significant(P<0.05);Syndrome basis of evaluation standards,the treatment group and thecontrol group were tested by two groups of Chinese statistically significant difference(p< 0.05).Conclusion:yiyuanfuzhi self-treament have certain clinical efficacy in the treatment of mild cognitive impairment with spleen and kidney dificiency and can improve MCI Neuropsychological scale scores of patients and chinese medicine clinical symptoms. To delay the progress of mild cognitive dysfunction has certain improvement action.